NR-568 · Week 5 of 8 · The medication review and polypharmacy

NR-568 Week 5 The Medication Review: How to Write It

The short answer

Polypharmacy is named in this course's catalog description, and the stage that addresses it directly asks for something students rarely practise: a structured review of a whole list rather than a decision about one drug. The territory is establishing what the patient is actually taking, matching every agent to an active indication, finding the drugs that exist only to treat the effects of other drugs, identifying the interactions and duplications that matter at these doses in this person, and producing a ranked set of problems. What is graded is a systematic examination. Your section may print this as NR 568 or NR568; it is the same course. Chamberlain publishes no syllabi outside Canvas. The placement here is our teaching judgment from the course's catalog arc; your section's rubric decides what your week actually asks.

NR-568 Week 5 grading scale at Chamberlain, the criterion levels this assessment is scored on, from Chamberlain Tutors
How Chamberlain grades NR-568 Week 5, visualized by Chamberlain Tutors.

What NR-568 Week 5 asks for

What makes a medication review a distinct skill rather than eight separate drug assessments? The relationships. A list of eleven medications contains information that none of the eleven entries carries on its own: two agents doing the same job, one prescribed to manage a side effect of another, a duplication created when a hospital discharge added a second name for a drug already being taken, and a total burden of agents acting on the same physiological system. Finding those requires a method, and the graded object at this stage is the method made visible on the page.

The clinic floor supplies the honest version of this. At a community health center annual review, a 77 year old man empties a shopping bag onto the desk. It contains nine prescription bottles, two of which came from a specialist he saw once, a supplement his daughter buys him, an over the counter analgesic he takes most days and does not consider a medicine, and a bottle belonging to his late wife that he has been using because it looked similar. The chart lists seven medications. The review starts by establishing which of those two lists is real, and that first step is the one most student papers skip entirely.

Deliverables at this depth are usually a structured review of a case list, sometimes presented partly as a table, and often a posted response. Look for a scoring row that asks you to prioritize, because a review that identifies fourteen problems without ranking them has produced an inventory rather than a plan, and prioritization is where clinical judgment becomes visible.

The course boundary holds here as elsewhere. Support covers the written and analytic layer of coursework built to a scoring guide. Clinical hours, preceptor documentation and medication decisions made for patients in your care are your own professional record and your own responsibility.

The NR-568 Week 5 method, step by step

Six moves for reviewing a list systematically on paper.

  1. Find the row that asks for prioritization

    Most review guides contain one, phrased as identify the most significant problems or similar. It is telling you that quantity of findings will not substitute for judgment about which of them matters most.

  2. Establish the actual list before analyzing it

    Say how you would determine what is being taken as opposed to what is recorded, including over the counter agents, supplements, topical products and anything obtained from another prescriber. A review of a chart list is a review of a document.

  3. Match every agent to an active indication

    One line per drug: why it is there and whether that reason still holds. Any agent whose indication you cannot state is a finding in itself and belongs near the top of the problem list.

  4. Look for drugs treating the effects of other drugs

    Trace each symptom being managed back to see whether another agent on the list could be producing it. Naming even one such chain is often the single most valuable paragraph in the paper.

  5. Screen for duplication and additive burden

    Two agents in the same class, the same drug under two names, and several agents acting on the same organ system or producing the same adverse effect. Additive burden is a finding even when no single agent is inappropriate.

  6. Rank the findings and say what ranked them

    Order by potential for harm, immediacy and reversibility, state the criterion you used, and name the two or three you would act on at this visit. A ranked list with a stated basis is what turns a review into a plan.

A layout and word budget for a medication review

The frame our tutors use for a structured review, sized for roughly 1,300 to 1,600 words. It is our own outline rather than a university template, and your section's scoring guide governs wherever the two differ.

SectionWhat belongs in itWord target
Establishing the true listHow you would verify what is actually taken, including the categories patients routinely omit from a report.180 to 220
Indication mappingEach agent matched to an active reason, with unmatched agents flagged as findings in their own right.240 to 290
Prescribing chainsAny drug present to manage the effect of another, traced explicitly from the first agent to the second.200 to 250
Interactions that matter hereTwo or three pairings at these doses in this person, each with mechanism, direction and consequence.250 to 300
Duplication and cumulative burdenSame class, same drug twice, and the total load acting on one system or producing one adverse effect.200 to 240
Ranked problem listThe findings ordered by a stated criterion, with the two or three you would address at this visit named.230 to 280

Evidence craft for medication review writing

Name the screening tool you used and use its language. Structured criteria for reviewing medications in older adults exist and are published, and applying a named one with its own categories lets a grader follow your reasoning against a standard rather than against your intuition.

Criteria are advisory, not verdicts. A drug flagged by a screening tool is a drug that requires justification, not a drug that must stop. Say what the flag means, then apply it to this patient, since the row is measuring application rather than lookup.

Interaction claims need magnitude and consequence. A database entry says two agents interact. Your paragraph has to say in which direction exposure moves, roughly how much, whether it matters at these doses, and what you would monitor or change. Without those, it is a list entry.

Report polypharmacy findings with their base and setting. Statements about how often adverse events follow from long medication lists come from studies in particular populations and settings, and both belong in the sentence alongside the number and the period.

Be careful with counts used as thresholds. Definitions of polypharmacy by number of medications vary between sources and are a crude proxy for risk. Cite the definition you are using with its source, and make the substantive argument about appropriateness rather than about the count.

Five mistakes that cost points in this week's territory

  • The chart list accepted as the real list. Reviewing what was recorded rather than what is taken misses the discrepancies that make these reviews worth doing.
  • Counting instead of assessing. Observing that a patient takes eleven medications is a description. Naming which three are unjustified and why is the assessment.
  • Every interaction reported. An exhaustive database dump buries the two that matter and demonstrates screening rather than judgment.
  • Prescribing chains missed entirely. A drug treating the effect of another drug is the highest-value finding available in this territory, and papers that never look for one leave it on the table.
  • Findings left unranked. Fourteen problems presented as equals give the reader no way to know what you would do first, and the prioritization row goes unanswered.
  • Posting a list you have not checked. Entries cannot be edited after submission at Chamberlain, and a misstated interaction direction is easy to spot and hard to retract.

Before you submit

  • The method for establishing the true list appears before any analysis
  • Every agent is matched to an indication, and unmatched agents are flagged
  • At least one possible prescribing chain is traced explicitly
  • Interactions are limited to those that matter, each with direction and consequence
  • Cumulative burden is assessed, not just individual appropriateness
  • The problem list is ranked and the ranking criterion is stated

Working a medication review this week?

Send the case list and the scoring guide out of Canvas. A premium original draft comes back in 24 to 48 hours with the chains traced and the problem list ranked against a stated criterion, and revisions run until the grade lands.

Questions students ask about this stage

How do I write about verifying the list when the case is just a chart extract?
Write the verification as a method you would apply and name what it typically uncovers, which keeps the section analytic rather than speculative. Describe asking the patient to bring every container including things they do not think of as medicines, checking dispensing records where available, asking specifically about topical products, eye preparations, supplements, herbal products and anything borrowed or shared, and asking separately about medications from other prescribers. Then say what you would expect to find: agents on the chart that stopped months ago, agents being taken that never reached the chart, and doses that differ from what was written. That paragraph shows you understand the reconciliation problem, and it costs you nothing that the case withheld the answers.
How do I decide which interactions are the important ones?
Use three filters and say that you used them. First, would the interaction change exposure enough to matter at the doses this patient actually takes, since many flagged pairings are trivial at low doses. Second, does the consequence carry real harm in this person, which depends on their organ function, their other agents and their circumstances. Third, is there something you would actually do differently as a result, whether that is a dose change, a switch, added monitoring or a timing separation. An interaction that passes all three deserves a full paragraph; one that fails the third belongs in a clause at most. Stating those filters explicitly in the paper is itself worth credit, because it shows the selection was deliberate rather than partial.
Should the review include what the patient wants?
Yes, and the better papers make it structural rather than decorative. A patient's view of which medications are burdensome, which they believe are helping and which they have quietly stopped taking is direct evidence about the list, and it frequently identifies the right target faster than a screening tool does. Write it as a source of findings: what you would ask, what a typical answer reveals, and how a stated preference would change your ranking. It also sets up the following stage of the course naturally, since any change to a long-standing list has to be agreed rather than announced, and a review that ignores the patient's own account of their medicines is working with half the available information.

Keep going

Online now